The inspection has concluded successfully on 1st September 2023 without any critical/major observation
The company has also started working with a large pharma company on the API supply of a recently launched animal and human health product
The inspection concluded with one minor observation in Form 483
The study, which enrolled 35 Japanese patients, evaluated the percent change from baseline in the 24-hour urine protein-to-creatinine ratio
Grangemouth serves as PPS’s dedicated antibody-drug conjugate development and manufacturing hub
With the addition of Phase II (~91 KL) in Q1 FY26, the combined capacity of the block now stands at ~200 KL
Hikal has reported total income of Rs. 381.4 crores during the period ended June 30, 2025
Ami Organics’ Ankleshwar Unit II gets GMP compliant by PMDA Japan
The inspection, conducted from March 17 to March 21, 2025, concluded with one observation in Form 483
Subscribe To Our Newsletter & Stay Updated
